BS Nursing Pharmacology-I
nmdcat.online June 6, 2026

153. A patient is receiving an investigational chemotherapy agent. The nurse’s priority in this situation is to:

A. Monitor for expected common side effects only.
B. Strictly adhere to the research protocol and monitor for all potential adverse effects.
C. Allow the patient to self-administer the drug.
D. Disregard patient complaints not listed as common side effects.

📖 Additional Information

  • Monitor for expected common side effects only.
  • Strictly adhere to the research protocol and monitor for all potential adverse effects.
  • Allow the patient to self-administer the drug.
  • Disregard patient complaints not listed as common side effects.

🔗 Share This Question

Categories

View all →